Following a turbulent Samvat 2082 characterized by market corrections, PL Capital expects corporate earnings to be the primary engine of equity returns over the next 12 months. The brokerage identified candidates based on technical patterns, moving averages, and oversold recovery indicators. Among these picks, Apollo Hospitals is projected to reach Rs 9,800 to Rs 10,400 after indicating a bottom near the Rs 7,500 zone. Other selections across engineering and metals, such as Jindal Steel, feature defined targets and stoploss levels to manage downside exposure.
Key points
Technical indicators such as weekly moving average defenses and chart patterns are guidin…: Technical indicators such as weekly moving average defenses and chart patterns are guiding PL Capital's festive stock selections.
Healthcare and industrial names feature prominent rebound setups, with stoploss levels st…: Healthcare and industrial names feature prominent rebound setups, with stoploss levels strictly defined across all recommended positions.
Anticipated corporate earnings growth is expected to drive overall equity market returns…: Anticipated corporate earnings growth is expected to drive overall equity market returns throughout the next twelve months.
Sources checked by our analysis pipeline: 1
Samvat 2082 proved challenging for Indian equities, marked by heightened volatility, intermittent recoveries and a significant correction in benchmark indices. Over the next 12 months, the sustainability and breadth of corporate earnings growth are likely to be the key drivers of equity market returns. Here are 10 stocks that look strong on charts.
Agencies
2/11
DLF
The brokerage has pegged the target price in the range of Rs 860-960 and a stoploss of Rs 570. The stock has been in consolidation for quite some time, sustaining above the important 200EMA at the Rs 623 level on the weekly chart & forming a higher bottom formation along with the VCP pattern in the daily chart. Currently having positive candle formation with volume participation to improve the bias, anticipating a further rise in the coming days. The RSI is well placed, and with a positive trend reversal indication and much upside potential visible, it can carry on with the positive move further ahead.
Agencies
3/11
Apollo Hospitals
The brokerage has pegged the target price in the range of Rs 9,800-10,400 and a…
The midcap IT services firm attracted strong market interest after delivering robust second-quarter financial results for FY27. Investors responded positively to sequential expansion across all geographic markets alongside expanding profitability margins. This operational turnaround offers a welcome boost to shareholder sentiment following a challenging year of substantial equity depreciation.
Market participants are closely watching trading activity as upward momentum lifts the company's valuation during today's session. Investors and analysts are actively tracking the sector for the underlying catalysts driving this positive market response. Further context regarding the exact corporate or broader market developments remains awaited.
Market participants are tracking downward movement in shares of AlzChem during current trading. The price action reflects selling pressure that has pushed the valuation lower for the session. Further market developments will determine how long this downward trajectory persists for the equity.